Publications by authors named "Yuqing Lian"
Article Synopsis
- - The study investigates the safety and effectiveness of combining toripalimab, an immune checkpoint inhibitor, with axitinib for treating non-metastatic clear cell renal cell carcinoma, focusing on clinical outcomes and biomarkers.
- - Conducted as a single-arm phase II trial with 20 enrolled patients, results showed a 45% objective response rate (ORR), with significant tumor shrinkage in 95% of participants before surgery.
- - Adverse events occurred in 25% of patients, including hypertension and elevated liver enzymes, while responders exhibited notable differences in certain immune factors compared to those with stable disease.
Imaging findings for pancreatic Hamartoma: two case reports and a review of the literature.
BMC Gastroenterol
February 2020
Background: Pancreatic hamartoma is an extremely rare benign disease, and previous reports have provided little detail regarding its appearance in imaging. As a result, we report the imaging findings for two cases of pancreatic hamartoma.
Case Presentation: One 57-year-old female patient and one 69-year-old male patient presented with pancreatic lesions incidentally detected by US; CT and MRI revealed a 2.
Background: It is important to distinguish the classification of lung adenocarcinoma. A radiomics model was developed to predict tumor invasiveness using quantitative and qualitative features of pulmonary ground-glass nodules (GGNs) on chest CT.
Materials And Methods: A total of 599 GGNs [including 202 preinvasive lesions and 397 minimally invasive and invasive pulmonary adenocarcinomas (IPAs)] were evaluated using univariate, multivariate, and logistic regression analyses to construct a radiomics model that predicted invasiveness of GGNs.